Extrapulmonary tuberculosis

During treatment, patients should be monitored monthly to assess symptoms, adherence to medications, and weight (with dose changes as needed). Monthly liver function tests (LFTs) may be recommended for those with abnormal baseline LFTs, chronic alcohol consumption, potential hepatotoxicity, other liver disease or injury (e.g., viral hepatitis), or HIV infection.[48]Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016 Oct 1;63(7):e147-95. https://cid.oxfordjournals.org/content/early/2016/07/20/cid.ciw376.full.pdf+html http://www.ncbi.nlm.nih.gov/pubmed/27516382?tool=bestpractice.com ​ Patients on ethambutol are monitored for visual disturbance and will need monthly vision checks. In patients with TB meningitis, repeated lumbar punctures are done to monitor changes in cell count, glucose, and protein.

At the completion of treatment, patients may have a follow-up imaging study to serve as a new baseline. In patients with multidrug-resistant TB, close follow up for 2 years after completion of treatment is recommended.